45,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
23 °P sammeln
  • Broschiertes Buch

Theoretical Chemistry in Action: In Silico Design of Multi-Target Cancer Inhibitors explores the power of computational methods in modern drug discovery. This book demonstrates how theoretical chemistry tools-such as QSAR modeling, molecular docking, and molecular dynamics simulations-can be integrated to design and optimize novel multi-target anti-cancer agents. It highlights the efficiency, precision, and predictive capability of in silico approaches in identifying potential inhibitors, reducing experimental costs, and accelerating the discovery of effective therapeutics. The work bridges…mehr

Produktbeschreibung
Theoretical Chemistry in Action: In Silico Design of Multi-Target Cancer Inhibitors explores the power of computational methods in modern drug discovery. This book demonstrates how theoretical chemistry tools-such as QSAR modeling, molecular docking, and molecular dynamics simulations-can be integrated to design and optimize novel multi-target anti-cancer agents. It highlights the efficiency, precision, and predictive capability of in silico approaches in identifying potential inhibitors, reducing experimental costs, and accelerating the discovery of effective therapeutics. The work bridges theoretical insights with practical applications, offering a valuable reference for researchers, students, and professionals in computational and medicinal chemistry.
Autorenporträt
Dr. Abdelmadjid Guendouzi is a researcher in theoretical and computational chemistry, specializing in Computer-Aided Drug Design (CADD). His work integrates DFT calculations, QSAR modeling, molecular docking, molecular dynamics simulations, and ADMET analysis to design and evaluate novel bioactive compounds.